CYCC - Cyclacel Pharmaceuticals GAAP EPS of -$0.44 beats by $0.06 revenue of $0.37M August, 09 2023 04:49 PM Cyclacel Pharmaceuticals Inc. 2023-08-09 16:49:00 ET Cyclacel Pharmaceuticals press release ( NASDAQ: CYCC ): Q2 GAAP EPS of -$0.44 beats by $0.06 . Revenue of $0.37M. For further details see: Cyclacel Pharmaceuticals GAAP EPS of -$0.44 beats by $0.06, revenue of $0.37M